Showing results (161-170 of 247) with videos related to

Sort By:
Pageof 25
Circulation|June 11, 1992
Suppression of longitudinal versus transverse conduction by sodium channel block. Effects of sodium bolusJ Turgeon, T A Wisialowski, W Wong, et al.
Clinical Pharmacology and Therapeutics|November 28, 2008
Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal studyT Rau, H Wuttke, L M Michels, et al.
The American Journal of Cardiology|October 1, 1996
Prediction of late cardiac events by dipyridamole thallium scintigraphy in patients with intermittent claudication and occult coronary artery diseaseD Darbar, N Gillespie, G Main, et al.
Clinical Pharmacology and Therapeutics|April 20, 2012
Clopidogrel: a case for indication-specific pharmacogeneticsJ A Johnson, D M Roden, L J Lesko, et al.
Circulation|May 1, 1987
Frequency- and orientation-dependent effects of mexiletine and quinidine on conduction in the intact dog heartA K Bajaj, H A Kopelman, J P Wikswo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 1991
Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricleM M Tamkun, K M Knoth, J A Walbridge, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Influence of genetic polymorphism on the metabolism and disposition of encainide in manT Wang, D M Roden, H T Wolfenden, et al.
Circulation|June 22, 1999
Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channelJ Wei, D W Wang, M Alings, et al.
Clinical Pharmacology and Therapeutics|July 1, 1993
Immediate- versus controlled-release disopyramide: importance of saturable bindingR F Davies, L A Siddoway, L Shaw, et al.
The American Journal of Cardiology|January 15, 1992
Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmiasW Wong, H N Pavlou, U M Birgersdotter, et al.
Pageof 25